AstraZeneca To Build $1.5 Bln Manufacturing Facility In Singapore For Antibody Drug Conjugates
20/5 08:21
(RTTNews) - British drug major AstraZeneca Plc. (AZN.L, AZN) announced Monday that it intends to build a $1.5 billion manufacturing facility in Singapore for antibody drug conjugates or ADCs with a view to supporting global supply of its ADC portfolio....